Pre-approval Expanded Access of Retatrutide (LY3437943)

NCT07629401 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Obesity
Obesity-related Complications

Interventions

DRUG: Retatrutide

Sponsor

Eli Lilly and Company